Lv3
215 积分 2020-08-03 加入
GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice
4天前
已完结
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
4天前
已完结
Revisiting energy expenditure: how to correct mouse metabolic rate for body mass
4天前
已完结
Systematic profiling of tumor-associated antigen expression for antibody-drug conjugate in prostate cancer
10天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
1个月前
已完结
Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling
1个月前
已完结
1616-P: Effect of Mazdutide on MASH Fibrosis—Targeting the Liver–Gut Axis and Microbiome
1个月前
已完结
Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A
1个月前
已完结
Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A
1个月前
已完结
皖公网安备34019202002308
